Commentary: The root of the matter
[摘要] In this edition of the Journal, Yerokun and colleagues1 use the power of linking Medicare claims data with the Society of Thoracic Surgeons database to provide insight into long-term outcomes of aortic root replacement (ARR) in Medicare beneficiaries. From 2004 to 2014, notable trends included more than a doubling in the use of stented bioprosthetic Bentall with decreasing use of mechanical Bentall, stentless Bentall, and valve-sparing root replacement (VSRR). These trends likely have been driven by the potential of valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) as a treatment for valve degeneration.
[发布日期] [发布机构]
[效力级别] [学科分类] 心脏病和心血管学
[关键词] [时效性]